Blueprint Medicines Corp 3 SEC Filings

Filed On	Filing
09 Jan 2023	Form 3: Tsai John, Director No securities owned
27 Jun 2022	Form 3: Dable Habib J, Director No securities owned
14 Apr 2022	Form 3: Lee Philina, Chief Commercial Officer Holds 20,354 shares of Common Stock
10 Dec 2021	Form 3: Tango Therapeutics, Inc., Director No securities owned
21 May 2021	Form 3: Carter Percy H., Chief Scientific Officer No securities owned
19 Jan 2021	Form 3: Hewes L. Becker, Chief Medical Officer Holds 17,500 shares of Common Stock
04 Sep 2020	Form 3: Namouni Fouad, President, R and D No securities owned
18 Feb 2020	Form 3: Durso-Bumpus Debra, Chief People Officer
15 Mar 2019	Form 3: Hurley Ariel, Principal Accounting Officer
05 Nov 2018	Form 3: Rossi Christina, Chief Commercial Officer No securities owned
10 Oct 2017	Form 3: Murray Christopher K., SVP, Technical Operations No securities owned
23 Nov 2016	Form 3: Dorsch Marion, Chief Scientific Officer No securities owned
12 Sep 2016	Form 3: McCain Tracey L, EVP and Chief Legal Officer No securities owned
15 Apr 2016	Form 3: Seely Lynn, Director No securities owned
05 Feb 2016	Form 3: Coats Lonnel, Director No securities owned
13 Jan 2016	Form 3: Haviland Kate, Chief Business Officer No securities owned
19 Aug 2015	Form 3: Landsittel Michael, Principal FAO
01 Jul 2015	Form 3: Goldberg Mark Alan, Director
30 Apr 2015	Form 3: Boral Anthony L., Sr. VP, Clinical Development
30 Apr 2015	Form 3: Albers Jeffrey W., Director Holds 143,486 shares of Common Stock

Comments